BUY Alivus Life Sciences Limited — Siddharth Rai Mangala

Entry₹1,416.6Inferred
Target₹1,530
Total upside +8.01% (call closed)
Stop loss₹1,375-2.94% risk
Exit₹1,37515 Sept 2026, 9:25 am
Stop-loss hit-2.94%

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 15 Sept 2026
2 supporting0 opposing
Supports the BUY call (2)

Alivus Life Sciences passes ₹5 dividend, approves FY26 results at AGM

NewsGoogle News·8 Sept · 6d ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·30 Jun · 3mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.